Gracell Biotechnologies Inc. Quarterly Cash and Cash Equivalents, at Carrying Value in CNY from Q4 2019 to Q2 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Gracell Biotechnologies Inc. quarterly Cash and Cash Equivalents, at Carrying Value history and growth rate from Q4 2019 to Q2 2023.
  • Gracell Biotechnologies Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending June 30, 2023 was ¥1.18B, a 22.8% decline year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (CNY)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 1.18B -351M -22.8% Jun 30, 2023 6-K 2023-08-14
Q4 2022 1.45B -374M -20.5% Dec 31, 2022 6-K 2023-08-14
Q2 2022 1.54B Jun 30, 2022 6-K 2022-08-15
Q4 2021 1.83B +1.07B +142% Dec 31, 2021 20-F 2023-04-25
Q4 2020 754M +442M +142% Dec 31, 2020 20-F 2022-04-22
Q4 2019 312M Dec 31, 2019 20-F 2021-04-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.